489 related articles for article (PubMed ID: 33359329)
21. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
22. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
[TBL] [Abstract][Full Text] [Related]
23. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
Micari A; Brodmann M; Keirse K; Peeters P; Tepe G; Frost M; Wang H; Zeller T;
JACC Cardiovasc Interv; 2018 May; 11(10):945-953. PubMed ID: 29798770
[TBL] [Abstract][Full Text] [Related]
24. Comparison of paclitaxel-coated balloon angioplasty with femoropopliteal bypass surgery in treating femoropopliteal lesions.
Kavala AA; Kuserli Y; Turkyilmaz S
Vascular; 2021 Apr; 29(2):260-269. PubMed ID: 32838692
[TBL] [Abstract][Full Text] [Related]
25. Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
Catheter Cardiovasc Interv; 2019 Mar; 93(4):664-672. PubMed ID: 30747489
[TBL] [Abstract][Full Text] [Related]
26. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results.
Cioppa A; Stabile E; Popusoi G; Salemme L; Cota L; Pucciarelli A; Ambrosini V; Sorropago G; Tesorio T; Agresta A; Biamino G; Rubino P
Cardiovasc Revasc Med; 2012; 13(4):219-23. PubMed ID: 22632996
[TBL] [Abstract][Full Text] [Related]
27. Matched comparison of uncoated and paclitaxel-coated balloon angioplasty for isolated popliteal lesions excluding bail-out stenting.
Böhme T; Noory E; Beschorner U; Bollenbacher R; Nührenberg T; Rastan A; Westermann D; Zeller T
Cardiovasc Revasc Med; 2024 Jun; 63():54-58. PubMed ID: 38245433
[TBL] [Abstract][Full Text] [Related]
28. Atherectomy plus drug-coated balloon versus drug-coated balloon only for treatment of femoropopliteal artery lesions: A systematic review and meta-analysis.
Lin F; Wang H; Ding W; Chen G; Zhang Z
Vascular; 2021 Dec; 29(6):883-896. PubMed ID: 33478353
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
Laird JA; Schneider PA; Jaff MR; Brodmann M; Zeller T; Metzger DC; Krishnan P; Scheinert D; Micari A; Wang H; Masters M; Tepe G
Circ Cardiovasc Interv; 2019 Jun; 12(6):e007702. PubMed ID: 31195825
[TBL] [Abstract][Full Text] [Related]
30. Midterm Outcomes of Drug-Coated Balloon Angioplasty in Femoropopliteal Lesions in a Daily Practice Cohort.
Nugteren M; Serné A; Verhoeven B; Koning O; van den Haak R; Scholtes V; Hinnen JW
Ann Vasc Surg; 2020 Apr; 64():188-197. PubMed ID: 31634609
[TBL] [Abstract][Full Text] [Related]
31. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
Yu C; Tang W; Ren T; Chen Q; Lu R; Gao Y
J Endovasc Ther; 2024 Jun; 31(3):390-399. PubMed ID: 36189843
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Adjunctive Drug-Coated Versus Uncoated Balloon after Atherectomy in Femoropopliteal Artery Disease.
Lee YJ; Ko YG; Ahn CM; Hong SJ; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
Ann Vasc Surg; 2020 Oct; 68():391-399. PubMed ID: 32339691
[TBL] [Abstract][Full Text] [Related]
33. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
[TBL] [Abstract][Full Text] [Related]
34. One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.
Feng Z; Yang S; Sang H; Xue G; Ni Q; Zhang L; Zhang W; Fang X; Ye M
J Endovasc Ther; 2021 Dec; 28(6):927-937. PubMed ID: 34251279
[TBL] [Abstract][Full Text] [Related]
35. Optical coherence tomography guided directional atherectomy with antirestenotic therapy for femoropopliteal arterial disease.
Stavroulakis K; Bisdas T; Torsello G; Argyriou A; Bollenberg L; Schwindt A
J Cardiovasc Surg (Torino); 2019 Apr; 60(2):191-197. PubMed ID: 30665284
[TBL] [Abstract][Full Text] [Related]
36. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
[TBL] [Abstract][Full Text] [Related]
37. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
[TBL] [Abstract][Full Text] [Related]
38. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
[TBL] [Abstract][Full Text] [Related]
39. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
[TBL] [Abstract][Full Text] [Related]
40. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I.
Xu Y; Jia X; Zhang J; Zhuang B; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W
JACC Cardiovasc Interv; 2018 Dec; 11(23):2347-2353. PubMed ID: 30448170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]